Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Natalizumab

Progression of lymphoma?: case report

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Phan-Ba R, Bisig B, Deprez M, De Prijck B, Delrue G, Herens C, Moonen G, Belachew S, De Leval L.Primary central nervous system lymphoma in a patient treated with Natalizumab. Annals of Neurology 69: 1060-1061, No. 6, Jun 2011. Available from: URL: http://dx.doi.org/10.1002/ana.22296 - Belgium

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Natalizumab. React. Wkly. 1363, 30 (2011). https://doi.org/10.2165/00128415-201113630-00117

    Download citation

    Keywords

    • Lymphoma
    • Multiple Sclerosis
    • Congenital Anomaly
    • Causal Link
    • Natalizumab